Yeung DT, Greenwood M, Rehn JA, Heatley SL, McClure B, Eadie LN, Breen J, Schutz CE, Sutton R, Trahair T, Frampton C, Wei A, Dalla-Pozza L, Bradstock K, Osborn MP, White DL. High risk genomic alterations identified at the time of diagnosis are strongly associated with MRD and subsequent poor outcomes in AYA ALL patients treated on a pediatric inspired chemotherapy regimen. Poster Presentation Orlando, Florida